MGLN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
MGLN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-05), Magellan Health's 12-1 Month Momentum % is 0.85%.
The industry rank for Magellan Health's 12-1 Month Momentum % or its related term are showing as below:
For the Healthcare Plans subindustry, Magellan Health's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Plans industry and Healthcare sector, Magellan Health's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Magellan Health's 12-1 Month Momentum % falls into.
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum % | = | ( Price 1-month ago | / | Price 12-month ago | - 1 ) | * | 100 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Magellan Health (NAS:MGLN) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Thank you for viewing the detailed overview of Magellan Health's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Mostafa Kamal | officer: CEO, Magellan Rx Management | 15950 NORTH 76TH STREET, #200 SCOTTSDALE AZ 85260 |
Jeffrey N West | officer: SVP & Controller | 6950 COLUMBIA GATEWAY DR STE 400 COLUMBIA MD 21046 |
David Bourdon | officer: Chief Financial Officer | 6303 COWBOYS WAY, SUITE 350, FRISCO TX 75034 |
Peter A Feld | director | 201 E LAS OLAS BOULEVARD, SUITE 1000, FORT LAUDERDALE FL 33301 |
Swati Bargotra Abbott | director | 4800 NORTH SCOTTSDALE ROAD, SUITE 4400, SCOTTSDALE AZ 85251 |
Steven J Shulman | director | 1564 NE EXPRESSWAY, ATTN: BJ PURCELL, ATLANTA GA 30329 |
Guy P Sansone | director | C/O MEDNAX, 1301 CONCORD TERRACE, SUNRISE FL 33323 |
Gregory Scott Mackenzie | director | NDC PLAZA ATLANTA GA 30329 |
Leslie V Norwalk | director | C/O 3661 VALLEY CENTRE DRIVE SUITE 200, SAN DIEGO CA 92130 |
Christopher J Chen | director | 4801 EAST WASHINGTON STREET PHOENIX AZ 85034 |
Mural R Josephson | director | |
James E Murray | officer: President and COO | 500 WEST MAIN STREET, LOUISVILLE KY 40202 |
Clapper Caskie Lewis | officer: Chief Human Resources Officer | 55 NOD ROAD AVON CT 06001 |
Kenneth J Fasola | director, officer: Chief Executive Officer | 500 WEST MAIN STREET, LOUISVILLE KY 40202 |
Jonathan N Rubin | officer: Chief Financial Officer | 55 NOD ROAD AVON CT 06001 |
From GuruFocus
By Business Wire Business Wire • 12-28-2021
By Business Wire Business Wire • 06-17-2021
By Business Wire Business Wire • 11-01-2021
By Business Wire Business Wire • 10-29-2021
By Business Wire Business Wire • 07-08-2021
By Business Wire Business Wire • 11-12-2021
By Business Wire Business Wire • 10-13-2021
By Business Wire Business Wire • 12-14-2021
By Business Wire Business Wire • 12-16-2021
By GuruFocus Research GuruFocus Editor • 08-24-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.